Penicillamine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Penicillamine and local guidelines before prescribing.

Chelating agent

Mechanism

Chelating agent and DMARD.

Uses

Wilson disease, severe rheumatoid arthritis, cystinuria.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Rash, taste loss, proteinuria and nephrotic syndrome, marrow suppression, drug-induced lupus, myasthenia.

Interactions

Antacids and iron reduce absorption.

Contraindications and cautions

SLE, renal impairment

Monitoring

FBC, urinalysis

Pregnancy and breastfeeding

Specialist advice

Renal and hepatic impairment

Avoid in renal impairment

Overdose and reversal

Supportive

Special advice

Take on an empty stomach; urine and blood monitoring.

More from the textbook: uses, cautions and other points
Where it is discussed in the book